Projects funded by the NCN
Next generation in vitro experimental model of melanoma for pharmacological studies
2014/15/B/NZ7/00947
Keywords:
melanoma genetic profile MAPK pathway inhibitors targeted tharapy vemurafenib trametinib
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_16: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 8 - announced on 2014-09-15
Amount awarded: 1 398 040 PLN
Project start date (Y-m-d): 2015-07-16
Project end date (Y-m-d): 2019-07-15
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled